Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
Bhavika K PatelTalal HilalMatthew CovingtonNan ZhangHeidi E KosiorekMarc LobbesDonald W NorthfeltBarbara A PockajPublished in: Annals of surgical oncology (2018)
CESM was comparable to MRI in assessing residual malignancy after completion of NST.
Keyphrases